sglt2 inhibitors vs glp-1 agonists Criteria for recommendation of or receptor Recommendations for SGLT2i versus GLP-1

Martinez de Tejada Weber, Genve (Gyncologie-obsttrique)

However, as the disease progresses, symptoms such as fatigue, abdominal discomfort, and unexplained weight loss may arise

It may be suitable for those primarily managing diabetes but also looking for mild weight loss benefits

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

(The brand-name GLP-1s arent available as generics because the patents havent expiredNovo Nordisk has its US patent on semaglutide until 2032, and Eli Lilly on tirzepatide, until 2036.) But to be clear, compounders do still operate within a regulatory framework, albeit a less stringent one

By the end of the study, all participants had achieved normal glucose tolerance